Unknown

Dataset Information

0

Combination GLP-1 and Insulin Treatment Fails to Alter Myocardial Fuel Selection vs. Insulin Alone in Type 2 Diabetes.


ABSTRACT: Context:It is unclear if effects of glucagon-like peptide-1 (GLP-1) and clinically available GLP-1 agonists on the heart occur at clinical doses in humans, possibly contributing to reduced cardiovascular disease risk. Objective:To determine whether liraglutide, at clinical dosing, augments myocardial glucose uptake (MGU) alone or combined with insulin compared with insulin alone in metformin-treated type 2 diabetes mellitus (T2D). Design:In a randomized clinical trial of patients with T2D treated with metformin plus oral agents or basal insulin, myocardial fuel use was compared after 3 months of treatment with insulin detemir, liraglutide, or combination detemir plus liraglutide added to background metformin. Main Outcome Measures:Myocardial blood flow (MBF), fuel selection, and rates of fuel use were evaluated using positron emission tomography, powered to demonstrate large effects. Results:MBF was greater in the insulin-treated groups [median (25th, 75th percentile): detemir, 0.64 mL/g/min (0.50, 0.69); liraglutide, 0.52 mL/g/min (0.46, 0.58); detemir plus liraglutide, 0.75 mL/g/min (0.55, 0.77); P = 0.035 comparing three groups, P = 0.01 comparing detemir groups to liraglutide alone]. There were no evident differences among groups in MGU [detemir, 0.040 µmol/g/min (0.013, 0.049); liraglutide, 0.055 µmol/g/min (0.019, 0.105); detemir plus liraglutide, 0.037 µmol/g/min (0.009, 0.046); P = 0.68 comparing three groups]. There were no treatment-group differences in measures of myocardial fatty acid uptake or handling, and no differences in total oxidation rate. Conclusion:These observations argue against large effects of GLP-1 agonists on myocardial fuel metabolism as mediators of beneficial treatment effects on myocardial function and ischemia protection.

SUBMITTER: Mather KJ 

PROVIDER: S-EPMC6126889 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Combination GLP-1 and Insulin Treatment Fails to Alter Myocardial Fuel Selection vs. Insulin Alone in Type 2 Diabetes.

Mather Kieren J KJ   Considine Robert V RV   Hamilton LaTonya L   Patel Niral A NA   Mathias Carla C   Territo Wendy W   Goodwill Adam G AG   Tune Johnathan D JD   Green Mark A MA   Hutchins Gary D GD  

The Journal of clinical endocrinology and metabolism 20180901 9


<h4>Context</h4>It is unclear if effects of glucagon-like peptide-1 (GLP-1) and clinically available GLP-1 agonists on the heart occur at clinical doses in humans, possibly contributing to reduced cardiovascular disease risk.<h4>Objective</h4>To determine whether liraglutide, at clinical dosing, augments myocardial glucose uptake (MGU) alone or combined with insulin compared with insulin alone in metformin-treated type 2 diabetes mellitus (T2D).<h4>Design</h4>In a randomized clinical trial of pa  ...[more]

Similar Datasets

| S-EPMC1158101 | biostudies-other
| S-EPMC3213132 | biostudies-literature
| S-ECPF-GEOD-37131 | biostudies-other
| S-EPMC3662998 | biostudies-literature
| S-EPMC8671299 | biostudies-literature
| S-EPMC8583813 | biostudies-literature
2023-06-29 | PXD043032 | Pride
| S-EPMC7192721 | biostudies-literature
| S-EPMC10361819 | biostudies-literature
| S-EPMC5897164 | biostudies-literature